Skip to search formSkip to main contentSkip to account menu

Treprostinil 2.5 MG/ML Injectable Solution [Remodulin]

Known as: Remodulin 2.5 MG/ML Injectable Solution, treprostinil 50 mg in 20 mL INTRAVENOUS INJECTION, SOLUTION [Remodulin], treprostinil 50 mg in 20 mL SUBCUTANEOUS INJECTION, SOLUTION [Remodulin] 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
  • 2016
  • Corpus ID: 6820140
The following therapies may be considered medically necessary for the treatment of pulmonary arterial hypertension (PAH/ WHO… 
2008
2008
Introduction:  As an initial pilot effort a prospective, case-controlled trial examining the effects of treprostinil sodium…